Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV

Abstract : Predicting vaccine efficacy remains a challenge. We used a systems vaccinology approach to identify early innate immune correlates of antibody induction in humans receiving the Ebola vaccine rVSV-ZEBOV. Blood samples from days 0, 1, 3, 7, and 14 were analyzed for changes in cytokine levels, innate immune cell subsets, and gene expression. Integrative statistical analyses with cross-validation identified a signature of 5 early innate markers correlating with antibody titers on day 28 and beyond. Among those, IP-10 on day 3 and MFI of CXCR6 on NK cells on day 1 were independent correlates. Consistently, we found an early gene expression signature linked to IP-10. This comprehensive characterization of early innate immune responses to the rVSV-ZEBOV vaccine in humans revealed immune signatures linked to IP-10. These results suggest correlates of vaccine-induced antibody induction and provide a rationale to explore strategies for augmenting the effectiveness of vaccines through manipulation of IP-10.
Liste complète des métadonnées

https://hal.inria.fr/hal-01579246
Contributeur : Boris Hejblum <>
Soumis le : mercredi 30 août 2017 - 17:11:48
Dernière modification le : jeudi 11 janvier 2018 - 11:34:35

Identifiants

Collections

Citation

Anne Rechtien, Laura Richert, Hadrien Lorenzo, Gloria Martrus, Boris P Hejblum, et al.. Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. Cell Reports , Elsevier Inc, 2017, 20 (9), pp.2251 - 2261. 〈10.1016/j.celrep.2017.08.023〉. 〈hal-01579246〉

Partager

Métriques

Consultations de la notice

68